Skip to main content

Advertisement

Log in

Obeticholic acid not cost effective for primary biliary cholangitis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Samur S, et al. Long-term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis. Hepatology : 7 Nov 2016. Available from: URL: http://doi.org/10.1002/hep.28932

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Obeticholic acid not cost effective for primary biliary cholangitis. PharmacoEcon Outcomes News 768, 25 (2016). https://doi.org/10.1007/s40274-016-3623-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3623-y

Navigation